You are currently viewing a new version of our website. To view the old version click .

Update on Prostate Cancer Diagnosis, Prognosis and Prediction to Response to Therapy

This special issue belongs to the section “Cellular Pathology“.

Special Issue Information

Research on molecular diagnostics in uro-oncology has progressed along with the development of complex emerging techniques, ranging from the application of next-generation sequencing platforms to archival pathology specimens, cytological samples, liquid biopsies, and to patient-derived tumour models. The identification of effective biomarkers has become a major focus, mainly due to the necessity of selecting potentially responsive patients and to improve their outcomes, as well as to reduce the toxicity and costs related to ineffective treatments. Diagnostic pathologists must integrate the information from pathological evaluation with the data from different sources to achieve a final diagnosis, prognosis, and prediction.

Prof. Rodolfo Montironi
Guest Editor

Prof. Antonio Lopez-Beltran
Dr. Alessia Cimadamore 
Prof. Liang Cheng
Dr. Marina Scarpelli 
Co-Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • Genitourinary tumours
  • Prostate cancer
  • Classification
  • Grading
  • Staging
  • Clinically significant prostate cancer
  • Castration-resistant prostate cancer
  • PSMA
  • Microbiome
  • Liquid biopsy
  • Circulating biomarkers
  • Circulating tumour cell (CTC)
  • Cell-free DNA (cfDNA)
  • Circulating tumour DNA (ctDNA)
  • Urine biomarkers
  • BRACA1
  • BRAC2
  • Defective DNA repair
  • PARP inhibitors
  • Immunotherapy
  • PD-L1
  • Atezolizumab
  • Avelumab
  • Durvalumab

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Published Papers

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Cells - ISSN 2073-4409